切换至 "中华医学电子期刊资源库"
高级检索
中华肝脏外科手术学电子杂志

中华肝脏外科手术学电子杂志 ›› 2025, Vol. 14 ›› Issue (04) : 631 -635. doi: 10.3877/cma.j.issn.2095-3232.2025.04.020

综述

肝癌围手术期营养风险筛查和肠内营养支持研究进展
陈佩玥1, 董芸1, 邓大炜1, 龚财芳1, 赵俊宇1, 游川1,2,†()   
  1. 1637000　四川省南充市，川北医学院附属医院肝胆外科
    2637000　四川省南充市，川北医学院肝胆胰肠疾病研究所
  • 收稿日期:2025-01-25 出版日期:2025-08-10
  • 通信作者: 游川
  • 基金资助:
    国家自然科学基金(82300737)

Research progress in perioperative nutritional risk screening and enteral nutritional support for liver cancer

Peiyue Chen1, Yun Dong1, Dawei Deng1, Caifang Gong1, Junyu Zhao1, Chuan You1,2,†()   

  1. 1Department of Hepatobiliary Surgery, Affiliated Hospital of North Sichuan Medical College, Nanchong 637000, China
    2Institute of Hepatobiliary, Pancreatic and Intestinal Diseases, North Sichuan Medical College, Nanchong 637000, China
  • Received:2025-01-25 Published:2025-08-10
  • Corresponding author: Chuan You
全文 ( ) 下载PDF ( ) 导出引用
引用本文：

陈佩玥, 董芸, 邓大炜, 龚财芳, 赵俊宇, 游川. 肝癌围手术期营养风险筛查和肠内营养支持研究进展[J/OL]. 中华肝脏外科手术学电子杂志, 2025, 14(04): 631-635.

Peiyue Chen, Yun Dong, Dawei Deng, Caifang Gong, Junyu Zhao, Chuan You. Research progress in perioperative nutritional risk screening and enteral nutritional support for liver cancer[J/OL]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2025, 14(04): 631-635.

肝癌是一种常见的恶性肿瘤，肝切除术是肝癌的首选治疗方式。肝癌患者术前出现不同程度的肝功能损伤，引起物质代谢异常。肝切除术后患者手术创伤大，应激反应强烈，往往出现营养不良。肝癌患者围手术期营养不良会抑制机体的修复能力、影响患者预后、并降低患者生存质量。因此，肝癌围手术期患者进行营养支持具有重要意义。肠内营养支持作为一种重要的营养支持方式，在肝癌围手术期的应用中逐渐受到关注。现围绕围手术期营养风险筛查、肠内营养支持时机、肠内营养支持途径及制剂等方面的最新研究进展作一综述，为肝癌患者的营养干预提供理论依据。

关键词: 癌，肝细胞, 围手术期, 肠内营养

Liver cancer is a common malignant tumor. Hepatectomy is the optimal treatment of liver cancer. Patients with liver cancer develop varying degrees of liver function impairment before surgery, leading to abnormal substance metabolism. After hepatectomy, patients experience severe surgical trauma and intense stress response, and often suffer from malnutrition. Perioperative malnutrition in patients with liver cancer will suppress the body’s repair ability, affect clinical prognosis and reduce the quality of life of patients. Therefore, it is of significance to provide perioperative nutritional support for patients with liver cancer. Enteral nutrition support, as a vital pattern of nutrition support, has gradually captivated attention in the perioperative application of liver cancer. In this article, the latest research progress in perioperative nutritional risk screening, the opportunity of enteral nutritional support, the patterns and preparations of enteral nutritional support were reviewed, aiming to provide theoretical basis for nutritional intervention in patients with liver cancer.

Key words: Carcinoma, hepatocelluar, Perioperative period, Enteral nutrition
[1]
中国抗癌协会肝癌专业委员会. 中国肿瘤整合诊治指南-肝癌(2022精简版)[J]. 中国肿瘤临床, 2022, 49(17): 865-873. DOI: 10.12354/j.issn.1000-8179.2022.20220942.
[2]
唐小丽, 王海清, 杨洁, 等. 肝癌合并肝硬化患者围手术期目标营养管理临床实践[J/CD]. 肿瘤代谢与营养电子杂志, 2021, 8(4): 408-413.
[3]
Maki H, Hasegawa K. Advances in the surgical treatment of liver cancer[J]. Biosci Trends, 2022, 16(3): 178-188. DOI: 10.5582/bst.2022.01245.
[4]
Qiu J, Wang Y. Effect of accelerated rehabilitation combined with enteral nutrition on gastrointestinal function recovery after hepatectomy[J]. Support Care Cancer, 2022, 30(11): 8927-8933. DOI: 10.1007/s00520-022-07290-1.
[5]
顾娇娇, 张慧玲, 邹燕, 等. 基于简易营养评价精法的肝癌住院患者营养状况评估及影响因素分析[J]. 当代护士, 2023, 30(29): 112-116. DOI: 10.19792/j.cnki.1006-6411.2023.29.026.
[6]
Guo ZQ, Yu JM, Li W, et al. Survey and analysis of the nutritional status in hospitalized patients with malignant gastric tumors and its influence on the quality of life[J]. Support Care Cancer, 2020, 28(1): 373-380. DOI: 10.1007/s00520-019-04803-3.
[7]
Nobs SP, Zmora N, Elinav E. Nutrition regulates innate immunity in health and disease[J]. Annu Rev Nutr, 2020, 40: 189-219. DOI: 10.1146/annurev-nutr-120919-094440.
[8]
Plauth M, Bernal W, Dasarathy S, et al. ESPEN guideline on clinical nutrition in liver disease[J]. Clin Nutr, 2019, 38(2): 485-521. DOI: 10.1016/j.clnu.2018.12.022.
[9]
Wang L, Wang X, Wang X. The effectiveness of enteral nutrition for patients with primary liver cancer: a randomized controlled study protocol[J]. Medicine, 2021, 100(3): e23973. DOI: 10.1097/MD.0000000000023973.
[10]
李建芳, 李杰. 结合营养风险筛查的术前营养补充对原发性肝癌术后并发症的影响[J]. 肿瘤基础与临床, 2022, 35(3): 256-258. DOI: 10.3969/j.issn.1673-5412.2022.03.019.
[11]
陈春霞, 徐冠华, 崔志明. 营养评估在肝癌患者治疗中的应用研究进展[J]. 南京医科大学学报(自然科学版), 2022, 42(10): 1488-1494. DOI: 10.7655/NYDXBNS20221023.
[12]
Li F, Ren Y, Fan J, et al. The predictive value of the preoperative albumin-to-fibrinogen ratio for postoperative hospital length of stay in liver cancer patients[J]. Cancer Med, 2023, 12(20): 20321-20331. DOI: 10.1002/cam4.6606.
[13]
Wang J, Tan S, Gianotti L, et al. Evaluation and management of body composition changes in cancer patients[J]. Nutrition, 2023, 114: 112132. DOI: 10.1016/j.nut.2023.112132.
[14]
Pokharel N, Katwal G, Adhikari SK. Comparison of preoperative nutritional risk index and body mass index for predicting immediate postoperative outcomes following major gastrointestinal surgery: cohort-study[J]. Ann Med Surg, 2019, 48: 53-58. DOI: 10.1016/j.amsu.2019.10.011.
[15]
Weimann A, Braga M, Carli F, et al. ESPEN guideline: clinical nutrition in surgery[J]. Clin Nutr, 2017, 36(3): 623-650. DOI: 10.1016/j.clnu.2017.02.013.
[16]
蒋慧. 营养风险筛查2002、营养不良通用筛查工具和患者主观整体评估在住院肿瘤患者中的应用[J]. 河南医学研究, 2020, 29(2): 226-228. DOI: 10.3969/j.issn.1004-437X.2020.02.012.
[17]
陈大宇, 卞晓洁, 于冬悦, 等. 肝癌肝切除术患者两种营养风险筛查工具的适用比较[J]. 药学与临床研究, 2018, 26(2): 130-134. DOI: 10.13664/j.cnki.pcr.2018.02.014.
[18]
Silva DMD, Henz AC, Fernandes SA, et al. Nutritional diagnosis of patients with hepatocellular carcinoma: what is the best method?[J]. Nutr Hosp, 2019, 36(4): 884-889. DOI: 10.20960/nh.02542.
[19]
Huang TH, Hsieh CC, Kuo LM, et al. Malnutrition associated with an increased risk of postoperative complications following hepatectomy in patients with hepatocellular carcinoma[J]. HPB, 2019, 21(9): 1150-1155. DOI: 10.1016/j.hpb.2019.01.003.
[20]
Lobo DN, Gianotti L, Adiamah A, et al. Perioperative nutrition: recommendations from the ESPEN expert group[J]. Clin Nutr, 2020, 39(11): 3211-3227. DOI: 10.1016/j.clnu.2020.03.038.
[21]
夏伟芬, 张坤, 谭炜. 早期肠内营养支持对肝癌术后患者胃肠功能恢复和营养状态的影响[J]. 浙江医学, 2023, 45(9): 955-958. DOI: 10.12056/j.issn.1006-2785.2023.45.9.2022-3286.
[22]
Hellerman Itzhaki M, Singer P. Advances in medical nutrition therapy: parenteral nutrition[J]. Nutrients, 2020, 12(3): 717. DOI: 10.3390/nu12030717.
[23]
Yao H, Bian X, Mao L, et al. Preoperative enteral nutritional support in patients undergoing hepatectomy for hepatocellular carcinoma: a strengthening the reporting of observational studies in epidemiology article[J]. Medicine, 2015, 94(46): e2006. DOI: 10.1097/MD.0000000000002006.
[24]
Weimann A, Braga M, Carli F, et al. ESPEN practical guideline: clinical nutrition in surgery[J]. Clin Nutr, 2021, 40(7): 4745-4761. DOI: 10.1016/j.clnu.2021.03.031.
[25]
Xiang Y, Zhang S, Cui Z, et al. Exploring the effect of microecological agents on postoperative immune function in patients undergoing liver cancer surgery: a systematic review and meta-analysis[J]. Ann Palliat Med, 2021, 10(11): 11615-11627. DOI: 10.21037/apm-21-2669.
[26]
李欢欢, 朱威丽, 戴诗婷, 等. 早期肠内营养支持对老年原发性肝癌患者TACE术后营养状态、肝功能及免疫功能的影响[J]. 航空航天医学杂志, 2020, 31(6): 750-751. DOI: 10.3969/j.issn.2095-1434.2020.06.064.
[27]
Xu Y, Wei FX. A retrospective study of enteral nutrition on immune and inflammatory factors after liver cancer surgery[J]. Medicine, 2021, 100(44): e27718. DOI: 10.1097/MD.0000000000027718.
[28]
Jiang Q, Xu T. Effect of early low-calorie enteral nutrition support in critically ill patients: a systematic review and meta-analysis[J]. Biomed Res Int, 2022, 2022: 7478373. DOI: 10.1155/2022/7478373.
[29]
Yan X, Liu L, Zhang Y, et al. Perioperative enteral nutrition improves postoperative recovery for patients with primary liver cancer: a randomized controlled clinical trial[J]. Nutr Cancer, 2021, 73(10): 1924-1932. DOI: 10.1080/01635581.2020.1814824.
[30]
Robledo-Valdez M, Cervantes-Pérez E, Cervantes-Guevara G, et al. Current concepts on preoperative nutritional support: how, when and why?[J]. Cir Cir, 2022, 90(4): 556-563. DOI: 10.24875/CIRU.20000893.
[31]
Ruiz-Margáin A, Román-Calleja BM, Moreno-Guillén P, et al. Nutritional therapy for hepatocellular carcinoma[J]. World J Gastrointest Oncol, 2021, 13(10): 1440-1452. DOI: 10.4251/wjgo.v13.i10.1440.
[32]
Cogo E, Elsayed M, Liang V, et al. Are supplemental branched-chain amino acids beneficial during the oncological peri-operative period: a systematic review and meta-analysis[J]. Integr Cancer Ther, 2021, 20: 1534735421997551. DOI: 10.1177/1534735421997551.
[33]
李地欢, 刘明, 江华. 《中国成年患者营养治疗通路指南》解读:外科空肠造口[J/CD]. 肿瘤代谢与营养电子杂志, 2022, 9(3): 293-297. DOI: 10.16689/j.cnki.cn11-9349/r.2022.03.005.
[34]
Fugazza A, Capogreco A, Cappello A, et al. Percutaneous endoscopic gastrostomy and jejunostomy: indications and techniques[J]. World J Gastrointest Endosc, 2022, 14(5): 250-266. DOI: 10.4253/wjge.v14.i5.250.
[35]
Wobith M, Weimann A. Postoperative nutrition management: who needs what?[J]. Visc Med, 2022, 38(5): 354-362. DOI: 10.1159/000526665.
[36]
吕俊玲, 夏路风, 胡咏川, 等. 肠内营养制剂基本特点及治疗中的药学监护[J]. 临床药物治疗杂志, 2020, 18(10): 76-79. DOI: 10.3969/j.issn.1672-3384.2020.10.017.
[37]
广东省药学会. 肠外肠内营养临床药学实践共识(2022年版)[J]. 今日药学, 2023, 33(6): 414-421. DOI: 10.12048/j.issn.1674-229X.2023.06.002.
[38]
Limketkai BN, Shah ND, Sheikh GN, et al. Classifying enteral nutrition: tailored for clinical practice[J]. Curr Gastroenterol Rep, 2019, 21(9): 47. DOI: 10.1007/s11894-019-0708-3.
[39]
张鸽文, 王志明. 肝脏手术病人围手术期营养支持[J]. 肠外与肠内营养, 2018, 25(5): 257-261. DOI: 10.16151/j.1007-810x.2018.05.001.
[40]
Shah ND, Barritt AS 4th. Nutrition as therapy in liver disease[J]. Clin Ther, 2022, 44(5): 682-696. DOI: 10.1016/j.clinthera.2022.04.012.
[41]
Wanden-Berghe C, Patino-Alonso MC, Galindo-Villardón P, et al. Complications associated with enteral nutrition: CAFANE study[J]. Nutrients, 2019, 11(9): 2041. DOI: 10.3390/nu11092041.
[42]
Hoffmann M, Schwarz CM, Fürst S, et al. Risks in management of enteral nutrition in intensive care units: a literature review and narrative synthesis[J]. Nutrients, 2020, 13(1): 82. DOI: 10.3390/nu13010082.
[43]
Whelan K, Schneider SM. Mechanisms, prevention, and management of diarrhea in enteral nutrition[J]. Curr Opin Gastroenterol, 2011, 27(2): 152-159. DOI: 10.1097/MOG.0b013e32834353cb.
[44]
Hammad A, Kaido T, Aliyev V, et al. Nutritional therapy in liver transplantation[J]. Nutrients, 2017, 9(10): 1126. DOI: 10.3390/nu9101126.
[45]
Elmahdi A, Eisa M, Omer E. Aspiration pneumonia in enteral feeding: a review on risks and prevention[J]. Nutr Clin Pract, 2023, 38(6): 1247-1252. DOI: 10.1002/ncp.11020.
[46]
Vadivelu N, Kodumudi G, Leffert LR, et al. Evolving therapeutic roles of nasogastric tubes: current concepts in clinical practice[J]. Adv Ther, 2023, 40(3): 828-843. DOI: 10.1007/s12325-022-02406-9.
[47]
Jia R, Zhao H, Yan X, et al. The effect of enteral nutrition nursing intervention on postoperative treatment of chronic critically ill patients: health prevention data analysis[J]. Prev Med, 2023, 174: 107635. DOI: 10.1016/j.ypmed.2023.107635.
[48]
Doley J. Enteral nutrition overview[J]. Nutrients, 2022, 14(11): 2180. DOI: 10.3390/nu14112180.
[49]
郑宇, 周冰倩, 龚妮. 肠内营养后高血糖的研究进展[J]. 中国普通外科杂志, 2023, 32(10): 1608-1616. DOI: 10.7659/j.issn.1005-6947.2023.10.020.
[50]
Ley D, Austin K, Wilson KA, et al. Tutorial on adult enteral tube feeding: indications, placement, removal, complications, and ethics[J]. JPEN J Parenter Enteral Nutr, 2023, 47(5): 677-685. DOI: 10.1002/jpen.2510.
[1] 邱益霖, 何坤. 肝细胞癌合并门静脉癌栓的治疗进展[J/OL]. 中华普通外科学文献(电子版), 2025, 19(03): 197-202.
[2] 翟耀君, 李丕嵩, 赵宏卿. 内镜下经乳晕径路实施单侧甲状腺癌手术对甲状腺功能的影响分析[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(03): 329-332.
[3] 卢超, 陈波, 邢志祥, 周鹏, 王帅. 不同入路下腹腔镜解剖性肝脏切除术治疗肝细胞癌的临床对比[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(03): 254-257.
[4] 陈琼, 吴卓龙, 黄吉炜. 免疫治疗在局部进展期肾癌围手术期治疗中的应用进展[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2025, 19(04): 418-422.
[5] 杨钰泽, 徐家豪, 杨一石, 王明达, 杨田. 肝细胞癌新辅助治疗进展[J/OL]. 中华肝脏外科手术学电子杂志, 2025, 14(04): 515-521.
[6] 罗臻, 韦鹏程, 孙馨, 李照. 肝细胞癌骨转移研究进展[J/OL]. 中华肝脏外科手术学电子杂志, 2025, 14(04): 522-527.
[7] 王楚斯, 刘家伟, 卢逸, 汤照峰. ICG荧光显影在腹腔镜肝癌切除术中临床应用[J/OL]. 中华肝脏外科手术学电子杂志, 2025, 14(04): 549-553.
[8] 匡嘉文, 陈铁军, 龚远锋, 唐辉, 唐云强. TACE-HAIC联合仑伐替尼和PD-1抑制剂四联治疗Ⅲa期肝癌的疗效[J/OL]. 中华肝脏外科手术学电子杂志, 2025, 14(04): 554-560.
[9] 彭艳红, 李乐, 刘中华, 刘蕊, 李鑫. 基于CiteSpace可视化分析MVI预测肝癌预后研究领域的热点及趋势[J/OL]. 中华肝脏外科手术学电子杂志, 2025, 14(04): 561-568.
[10] 吴添庆, 郑梽楷, 贺珉睿, 潘扬勋, 王骏成, 陈锦滨, 周仲国. 华蟾素治疗肝癌肝动脉灌注化疗术后疼痛的疗效和安全性[J/OL]. 中华肝脏外科手术学电子杂志, 2025, 14(04): 569-575.
[11] 张宏伟, 邢玉雪, 贾哲, 赫嵘, 张珂, 蒋力. 术前输注血小板在肝癌合并肝硬化门静脉高压症肝脾联合切除患者中的疗效[J/OL]. 中华肝脏外科手术学电子杂志, 2025, 14(04): 576-581.
[12] 刘晓萍, 汪嵘嵘, 吴佳慧, 吴紫云, 周伯宣. 多组学分析HAPLN1与肝癌预后及免疫细胞浸润关系[J/OL]. 中华肝脏外科手术学电子杂志, 2025, 14(04): 609-618.
[13] 郭勇, 贾思颖, 高士杰, 涂康生. RNFT2在肝细胞癌中表达及其对细胞增殖、侵袭和患者预后影响[J/OL]. 中华肝脏外科手术学电子杂志, 2025, 14(04): 619-627.
[14] 张铭燊, 胡永威, 陈德盛, 俞浩远, 梁智星, 陈玉涛, 叶林森, 李华, 杨扬. CEBPZOS通过调控肿瘤增殖与迁移促进肝癌进展的机制研究[J/OL]. 中华肝脏外科手术学电子杂志, 2025, 14(03): 463-470.
[15] 龙吟, 何晓东, 廖建国, 黄珏, 张磊. 高复发风险肝癌患者术后靶向免疫治疗的安全性及疗效[J/OL]. 中华肝脏外科手术学电子杂志, 2025, 14(03): 379-386.
阅读次数
全文


摘要

版权所有 中华医学会 中华医学电子音像出版社有限责任公司  京ICP备14006079号-1  网络出版服务许可证：(署)网出证(京)字第075号